Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern
Clinical trial NCT03478982 · COMPLETED
Trial details
- NCT number
- NCT03478982
- Sponsor
- Engage Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2019-12-22
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.